用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Terbutaline'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页68 条记录, 当前第1/7页。
公开号 公开日 申请号 申请日
1. CN103520096A 2014/1/22
专利标题:A kind of production technology of terbutaline sulphate injection 法律状态
专利权人


2. CN102416167B 2013/6/5
专利标题:The atomized inhalation of interferon-alpha and terbutaline sulphate 法律状态


3. CN102961365A 2013/3/13 CN20121548234 2012/12/17
专利标题:Terbutaline sulfate oral instant film and preparation method thereof 法律状态


4. US2012196938A1 2012/8/2
专利标题:Beta 2 Adrenergic Receptor Agonists Such As Terbutaline for Use in the Treatment of Nocturnal Hypoglycemia 法律状态
The invention is concerned with methods, regimens and dosage forms employing a beta 2 adrenergic receptor agonist such as terbutaline sulphate, for treating nocturnal hypoglycaemia in human subjects whilst reducing incidence of hyperglycaemia in said subjects upon wakening.


5. US20120196938A1 2012/8/2
专利标题:Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia 法律状态
专利权人JAGOTEC AG;
The invention is concerned with methods regimens and dosage forms employing a beta 2 adrenergic receptor agonist such as terbutaline sulphate for treating nocturnal hypoglycaemia in human subjects whilst reducing incidence of hyperglycaemia in said subjects upon wakening.


6. EP2456430A1 2012/5/30 EP20100731762 2010/7/16
专利标题:BETA 2 ADRENERGIC RECEPTOR AGONISTS SUCH AS TERBUTALINE FOR USE IN THE TREATMENT OF NOCTURNAL HYPOGLYCEMIA 法律状态
专利权人JAGOTEC AG [CH];


7. CN101475497B 2012/4/18
专利标题:The method of the terbutaline sulphate crystal b of preparation fulfilling medicinal requirements 法律状态
专利权人Li Qingeng;


8. CN102416167A 2012/4/18 CN20111407570 2011/12/8
专利标题:Aerosol inhalant containing interferon alpha and terbutaline sulfate 法律状态


9. JP2011079841A 2011/4/21 JP20100255113 2010/11/15
专利标题:Formulation containing active ingredient and cacao powder, and use thereof 法律状态
专利权人MCNEIL AB;
PROBLEM TO BE SOLVED: To provide a pharmaceutical formulation orally administrable of one or a plurality of active pharmaceutical ingredients (API) for providing quick oral intake. SOLUTION: There are provided a pharmaceutical formulation containing one or a plurality of APIs suitable for oral intake and cacao powder a method for producing the formulation and use of the formulation for therapy. As the APIs eletriptan terbutaline sulfate triazolam maleic acid chlorophenylamine dextropropoxyphene...


10. WO2011009818A1 2011/1/27 WO2010EP60326 2010/7/16
专利标题:BETA 2 ADRENERGIC RECEPTOR AGONISTS SUCH AS TERBUTALINE FOR USE IN THE TREATMENT OF NOCTURNAL HYPOGLYCEMIA 法律状态
The invention is concerned with methods, regimens and dosage forms employing a beta 2 adrenergic receptor agonist such as terbutaline sulphate, for treating nocturnal hypoglycaemia in human subjects whilst reducing incidence of hyperglycaemia in said subjects upon wakening.



首页123456下页尾页68 条记录, 当前第1/7页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文